piperazine has been researched along with Nervous System Diseases in 5 studies
Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cisar, JS | 1 |
| Weber, OD | 1 |
| Clapper, JR | 1 |
| Blankman, JL | 1 |
| Henry, CL | 1 |
| Simon, GM | 1 |
| Alexander, JP | 1 |
| Jones, TK | 1 |
| Ezekowitz, RAB | 1 |
| O'Neill, GP | 1 |
| Grice, CA | 1 |
| Jiang, M | 1 |
| van der Stelt, M | 1 |
| HANNAH, EE | 1 |
| ELIACHAR, E | 1 |
| PAVLOTSKY, D | 1 |
| TASSY, R | 1 |
| Buemi, M | 1 |
| Di Maria, F | 1 |
| Molinaro, M | 1 |
| Tripodi, F | 1 |
| Aloisi, C | 1 |
| Musolino, R | 1 |
5 other studies available for piperazine and Nervous System Diseases
| Article | Year |
|---|---|
Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders.
Topics: Animals; Dogs; Dose-Response Relationship, Drug; Drug Discovery; Humans; Male; Mice; Molecular Targe | 2018 |
Activity-Based Protein Profiling Delivers Selective Drug Candidate ABX-1431, a Monoacylglycerol Lipase Inhibitor, To Control Lipid Metabolism in Neurological Disorders.
Topics: Clinical Trials, Phase I as Topic; Enzyme Inhibitors; Humans; Lipid Metabolism; Monoacylglycerol Lip | 2018 |
The neurotoxic effect of piperazine; report of a case.
Topics: Humans; Nervous System Diseases; Piperazine; Piperazines | 1958 |
[Neurological complications after use of piperazine as a vermifuge].
Topics: Anthelmintics; Ascariasis; Child; Electroencephalography; Humans; Infant; Nervous System Diseases; N | 1960 |
Acute piperazine encephalopathy in a hemodialyzed patient.
Topics: Antinematodal Agents; Drug Overdose; Electroencephalography; Female; Hemoperfusion; Humans; Middle A | 1995 |